Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Report Points To Benefits Of PET Scans In Cancer Management

This article was originally published in The Gray Sheet

Executive Summary

Twenty-one leading cancer centers stress the value of positron emission tomography in cancer management in a June 5 1report

You may also be interested in...



Enthusiasm For Hybrid PET/MR Scanner Meets Questions Of Practicality

James Thrall, the radiologist-in-chief at Massachusetts General Hospital, could barely contain his excitement about being among the first clinicians to receive a prototype imaging system from Siemens that he says will revolutionize our understanding of how the mind works

Enthusiasm For Hybrid PET/MR Scanner Meets Questions Of Practicality

James Thrall, the radiologist-in-chief at Massachusetts General Hospital, could barely contain his excitement about being among the first clinicians to receive a prototype imaging system from Siemens that he says will revolutionize our understanding of how the mind works

HHS Oncology Biomarker Initiative May Enhance Imaging And Assay Adoption

A new HHS initiative to improve the drug development process could hasten adoption of innovative imaging and diagnostic technologies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel